The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AGILE THERAPEUTICS INC COM 00847L100 18,940 2,171,831 SH   SOLE   2,171,831 0 0
AMBIT BIOSCIENCES CORP COM 02318X100 11,400 1,650,156 SH   SOLE   1,650,156 0 0
CEMPRA INC COM 15130J109 35,330 3,293,060 SH   SOLE   3,293,060 0 0
CEMPRA INC COM 15130J109 429 40,000 SH Call SOLE   0 0 0
CHIMERIX INC COM 16934W106 33,410 1,522,943 SH   SOLE   1,522,943 0 0
DURATA THERAPEUTICS INC COM 26658A107 34,570 2,030,175 SH   SOLE   2,030,175 0 0
ESPERION THERAPEUTICS INC NE COM 29664W105 32,540 2,054,594 SH   SOLE   2,054,594 0 0
LOMBARD MED INC COM G55598109 6,380 886,363 SH   SOLE   886,363 0 0
MEI PHARMA INC COM NEW 55279B202 4,880 770,000 SH   SOLE   770,000 0 0
PERNIX THERAPEUTICS HLDGS IN COM 71426V108 18,050 2,010,000 SH   SOLE   2,010,000 0 0
PERNIX THERAPEUTICS HLDGS IN COM 71426V108 90 10,000 SH Call SOLE   0 0 0
SORRENTO THERAPEUTICS INC COM NEW 83587F202 11,900 1,763,500 SH   SOLE   1,763,500 0 0
TRANSENTERIX INC COM NEW 89366M201 42,010 8,335,819 SH   SOLE   8,335,819 0 0
VERSARTIS INC COM 92529L102 55,090 1,964,568 SH   SOLE   1,964,568 0 0
ZELTIQ AESTHETICS INC COM 98933Q108 39,460 2,597,742 SH   SOLE   2,597,742 0 0
ZELTIQ AESTHETICS INC COM 98933Q108 657 43,261 SH Call SOLE   0 0 0